动态高氧试验联合脑氧分压监测检测脑低灌注
单中心研究纳入53例急性脑损伤患者(TBI 17例、SAH 29例、ICH 7例),共完成87次CT灌注(CTP)检查,同步记录ICP和PbtO2,并在CTP前将FiO2从基线直接升至100%持续20分钟(标准诊疗),计算氧比(OxR=ΔPbtO2/ΔPaO2)。以CTP测得的局部脑血流量(rCBF)<35 mL/100 g×min定义脑低灌注,56次(64%)CTP存在低灌注。ICP+PbtO2预测脑低灌注的AUC为0.78(95%CI 0.68-0.87),ICP+PbtO2+OxR为0.80(0.70-0.91),均显著优于单独ICP(AUC=0.65,95%CI 0.53-0.76);不同病因间准确性无显著差异。联合ICP与PbtO2监测可更好地检出急性脑损伤患者的脑低灌注,但动态高氧试验未能显著提高诊断准确性。
要点
- 以CTP的rCBF<35 mL/100 g×min定义脑低灌注,87次CTP中56次(64%)存在低灌注。
- ICP+PbtO2预测脑低灌注AUC=0.78(95%CI 0.68-0.87),ICP+PbtO2+OxR为0.80(0.70-0.91),均优于单独ICP(AUC=0.65,95%CI 0.53-0.76)。
- rCBF与ICP(r=-0.27,p=0.01)、PbtO2(r=0.36,p<0.01)、OxR(r=0.57,p<0.01)相关。
- 不同脑损伤病因(TBI、SAH、ICH)间的预测准确性无显著差异。
- 动态高氧试验(FiO2升至100%持续20分钟)计算的OxR未能显著提高诊断准确性。
适用人群与场景
- 纳入TBI(n=17)、SAH(n=29)、ICH(n=7)的急性脑损伤患者,共53例,中位年龄52(41-63)岁。
- 在ICU行ICP和PbtO2监测并接受CTP检查的患者。
诊断标准与关键阈值
- 脑低灌注定义:CTP测得的局部脑血流量(rCBF)<35 mL/100 g×min。
- 氧比(OxR)计算公式:OxR=ΔPbtO2/ΔPaO2。
处置流程与药物剂量
- CTP检查前,在病情稳定条件下将FiO2从基线直接升至100%持续20分钟,作为标准诊疗用于测试PbtO2导管。
- 在FiO2 100%时记录脑监测数据并采血,测定PaO2和PbtO2,计算OxR。
- 由对PbtO2值不知情的独立放射科医生在颅内监测探头周围组织区域用CTP测量rCBF。
研究设计与关键结果
- 单中心研究,53例患者共完成87次CTP;脑低灌注见于56次(64%)CTP。
- 有低灌注与无低灌注的CTP之间,ICP、PbtO2和OxR均存在显著差异。
- rCBF与ICP相关(r=-0.27;p=0.01),与PbtO2相关(r=0.36;p<0.01),与OxR相关(r=0.57;p<0.01)。
- 单独ICP预测脑低灌注AUC=0.65(95%CI 0.53-0.76);ICP+PbtO2的AUC=0.78(95%CI 0.68-0.87);ICP+PbtO2+OxR的AUC=0.80(95%CI 0.70-0.91);联合监测均显著优于单独ICP。
- 不同脑损伤病因间的预测准确性无显著差异。
证据类型、等级与局限
- 单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在急性脑损伤患者中,ICP联合PbtO2监测比单独ICP监测能更好地检测脑低灌注。
- 动态高氧试验计算的OxR未能显著提高诊断准确性,作者认为其未显著增加诊断准确性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Brain multimodal monitoring including intracranial pressure (ICP) and brain tissue oxygen pressure (PbtO2) is more accurate than ICP alone in detecting cerebral hypoperfusion after traumatic brain injury (TBI). No data are available for the predictive role of a dynamic hyperoxia test in brain-injured patients from diverse etiology.
AIM: To examine the accuracy of ICP, PbtO2 and the oxygen ratio (OxR) in detecting regional cerebral hypoperfusion, assessed using perfusion cerebral computed tomography (CTP) in patients with acute brain injury.
METHODS: Single-center study including patients with TBI, subarachnoid hemorrhage (SAH) and intracranial hemorrhage (ICH) undergoing cerebral blood flow (CBF) measurements using CTP, concomitantly to ICP and PbtO2 monitoring. Before CTP, FiO2 was increased directly from baseline to 100% for a period of 20 min under stable conditions to test the PbtO2 catheter, as a standard of care. Cerebral monitoring data were recorded and samples were taken, allowing the measurement of arterial oxygen pressure (PaO2) and PbtO2 at FiO2 100% as well as calculation of OxR (= ΔPbtO2/ΔPaO2). Regional CBF (rCBF) was measured using CTP in the tissue area around intracranial monitoring by an independent radiologist, who was blind to the PbtO2 values. The accuracy of different monitoring tools to predict cerebral hypoperfusion (i.e., CBF < 35 mL/100 g × min) was assessed using area under the receiver-operating characteristic curves (AUCs).
RESULTS: Eighty-seven CTPs were performed in 53 patients (median age 52 [41-63] years-TBI, n = 17; SAH, n = 29; ICH, n = 7). Cerebral hypoperfusion was observed in 56 (64%) CTPs: ICP, PbtO2 and OxR were significantly different between CTP with and without hypoperfusion. Also, rCBF was correlated with ICP (r = - 0.27; p = 0.01), PbtO2 (r = 0.36; p < 0.01) and OxR (r = 0.57; p < 0.01). Compared with ICP alone (AUC = 0.65 [95% CI, 0.53-0.76]), monitoring ICP + PbO2 (AUC = 0.78 [0.68-0.87]) or ICP + PbtO2 + OxR (AUC = 0.80 (0.70-0.91) was significantly more accurate in predicting cerebral hypoperfusion. The accuracy was not significantly different among different etiologies of brain injury.
CONCLUSIONS: The combination of ICP and PbtO2 monitoring provides a better detection of cerebral hypoperfusion than ICP alone in patients with acute brain injury. The use of dynamic hyperoxia test could not significantly increase the diagnostic accuracy.
参考来源
- Gargadennec T, Ferraro G, Chapusette R, et al. Detection of cerebral hypoperfusion with a dynamic hyperoxia test using brain oxygenation pressure monitoring. Crit Care. 2022. PMID: 35130953. doi:10.1186/s13054-022-03918-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。